← Insider buys
ARPO

Aerpio Pharmaceuticals, Inc.

Orbimed Advisors LLC sold $42K of Aerpio Pharmaceuticals, Inc.

10% owner

Sold$41,944
$1.96Price
21,400Shares

What ARPO did after the filing

Prices for ARPO after this filing aren't in yet.

Traded Tue, Dec 8. Filed Thu, Dec 10, 5:04 PM ET, after the close. Not investment advice.